AZ, Amgen’s asthma hope tezepelumab flunks phase 3 trialAstraZeneca and Amgen looked on course to cruise to approval of their severe asthma drug tezepelumab with a Share XAZ, Amgen’s asthma hope tezepelumab flunks phase 3 trialhttps://pharmaphorum.com/news/az-amgens-asthma-hope-tezepelumab-flunks-phase-3-trial/
Breakthrough designation AstraZeneca’s severe asthma drugThe first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after Share XBreakthrough designation AstraZeneca’s severe asthma drughttps://pharmaphorum.com/news/astrazeneca-asthma-breakthrough/
